Correlation Between Century Therapeutics and ACELYRIN, INC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Century Therapeutics and ACELYRIN, INC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Century Therapeutics and ACELYRIN, INC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Century Therapeutics and ACELYRIN, INC Common, you can compare the effects of market volatilities on Century Therapeutics and ACELYRIN, INC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Century Therapeutics with a short position of ACELYRIN, INC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Century Therapeutics and ACELYRIN, INC.

Diversification Opportunities for Century Therapeutics and ACELYRIN, INC

-0.15
  Correlation Coefficient

Good diversification

The 3 months correlation between Century and ACELYRIN, is -0.15. Overlapping area represents the amount of risk that can be diversified away by holding Century Therapeutics and ACELYRIN, INC Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACELYRIN, INC Common and Century Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Century Therapeutics are associated (or correlated) with ACELYRIN, INC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACELYRIN, INC Common has no effect on the direction of Century Therapeutics i.e., Century Therapeutics and ACELYRIN, INC go up and down completely randomly.

Pair Corralation between Century Therapeutics and ACELYRIN, INC

Given the investment horizon of 90 days Century Therapeutics is expected to generate 1.0 times more return on investment than ACELYRIN, INC. However, Century Therapeutics is 1.0 times less risky than ACELYRIN, INC. It trades about 0.04 of its potential returns per unit of risk. ACELYRIN, INC Common is currently generating about 0.02 per unit of risk. If you would invest  164.00  in Century Therapeutics on September 2, 2024 and sell it today you would earn a total of  8.00  from holding Century Therapeutics or generate 4.88% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Century Therapeutics  vs.  ACELYRIN, INC Common

 Performance 
       Timeline  
Century Therapeutics 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Century Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Century Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
ACELYRIN, INC Common 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ACELYRIN, INC Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, ACELYRIN, INC may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Century Therapeutics and ACELYRIN, INC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Century Therapeutics and ACELYRIN, INC

The main advantage of trading using opposite Century Therapeutics and ACELYRIN, INC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Century Therapeutics position performs unexpectedly, ACELYRIN, INC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACELYRIN, INC will offset losses from the drop in ACELYRIN, INC's long position.
The idea behind Century Therapeutics and ACELYRIN, INC Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Transaction History
View history of all your transactions and understand their impact on performance
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities